Marfrig Global Foods SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Marfrig Global Foods SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C0997
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Marfrig Global Foods SA – Strategy, SWOT and Corporate Finance Report
Summary

Marfrig Global Foods SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Marfrig Global Foods SA (Marfrig) is a meat processing company. Its product portfolio includes fresh and processed beef, pork, lamb, poultry, pasta, frozen vegetables, desserts, breaded products and ready-to-eat meals. Marfrig also offers fish, semi-finished and finished leather. The company markets its products under Marfrig Angus, Marfrig, Pampeano, La Morocha and Keystone brands and sell these in domestic and several international markets. Marfrig operates production, commercial and distribution units in countries across South America, North America, Europe, Oceania and Asia. The company supplies its products to restaurants, supermarket chains, food processing companies, and individual consumers. Marfrig is headquartered in Sao Paulo, Brazil.

Scope

- Detailed information on Marfrig Global Foods SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Marfrig Global Foods SA in the form of a SWOT analysis
- An in-depth view of the business model of Marfrig Global Foods SA including a breakdown and examination of key business segments
- Intelligence on Marfrig Global Foods SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Marfrig Global Foods SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Marfrig Global Foods SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Marfrig Global Foods SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Marfrig Global Foods SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Marfrig Global Foods SA: Company Overview 9
Marfrig Global Foods SA: Overview and Key Facts 9
Marfrig Global Foods SA: Overview 9
Marfrig Global Foods SA: Key Facts 9
Marfrig Global Foods SA: Key Employees 11
Marfrig Global Foods SA: Key Employee Biographies 12
Marfrig Global Foods SA: Major Products and Services 13
Marfrig Global Foods SA: Company History 14
Marfrig Global Foods SA: Management Statement 16
Marfrig Global Foods SA: Locations and Subsidiaries 17
Marfrig Global Foods SA: Key Competitors 18
Marfrig Global Foods SA: Company Analysis 19
Marfrig Global Foods SA: Business Description 19
Marfrig Global Foods SA: SWOT Analysis 20
Marfrig Global Foods SA: SWOT Overview 20
Marfrig Global Foods SA: Strengths 20
Marfrig Global Foods SA: Weaknesses 21
Marfrig Global Foods SA: Opportunities 21
Marfrig Global Foods SA: Threats 22
Marfrig Global Foods SA: Corporate Financial Deals Activity 23
Marfrig Global Foods SA: Financial Deals Overview 23
Marfrig Global Foods SA: Targets and Partners 25
Marfrig Global Foods SA: Top Deals 2014 – 2018YTD* 26
Marfrig Global Foods SA: Advisors 27
Marfrig Global Foods SA: Top Legal Advisors 27
Marfrig Global Foods SA: Top Financial Advisors 27
Marfrig Global Foods SA: Mergers and Acquisitions 28
Marfrig Global Foods SA: Capital Raising 29
Marfrig Global Foods SA: Recent Developments 30
Marfrig Global Foods SA: News and Events Summary 30
Marfrig Global Foods SA: Corporate Governance 30
Marfrig Global Foods SA: Financial Performance 31
Appendix 32
Contact Us 32
Methodology 32
About MarketLine 33

List of Tables
Table 1: Marfrig Global Foods SA: Key Facts
Table 2: Marfrig Global Foods SA: Key Employees
Table 3: Marfrig Global Foods SA: Locations and Subsidiaries
Table 4: Marfrig Global Foods SA: Key Competitors
Table 5: Marfrig Global Foods SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Marfrig Global Foods SA: M&A Activity by Geography (TTM*)
Table 7: Marfrig Global Foods SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Marfrig Global Foods SA: M&A Average Deal Size - Value (US$m)
Table 9: Marfrig Global Foods SA: Targets and Partners
Table 10: Marfrig Global Foods SA: Top Deals 2014 - 2018YTD*
Table 11: Marfrig Global Foods SA: Legal Advisor Ranking by Value (US$m)
Table 12: Marfrig Global Foods SA: Financial Advisor Ranking by Value (US$m)
Table 13: Marfrig Global Foods SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Marfrig Global Foods SA: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Marfrig Global Foods SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 16: Marfrig Global Foods SA: Capital Raising by Deal Type (2014 - YTD*2018)
Table 17: Marfrig Global Foods SA: News and Events Summary
Table 18: Marfrig Global Foods SA: Corporate Governance
Table 19: Marfrig Global Foods SA: Financial Performance

List of Figures
Figure 1: Marfrig Global Foods SA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Marfrig Global Foods SA: M&A Activity by Geography (TTM*)
Figure 3: Marfrig Global Foods SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Marfrig Global Foods SA: M&A Average Deal Size - Value (US$m)
Figure 5: Marfrig Global Foods SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Marfrig Global Foods SA: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Marfrig Global Foods SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Marfrig Global Foods SA: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Marfrig Global Foods SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Koninklijke Philips NV (PHIA):企業の財務・戦略的SWOT分析
    Koninklijke Philips NV (PHIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Varian Medical Systems Inc (VAR):医療機器:M&Aディール及び事業提携情報
    Summary Varian Medical Systems Inc (VMS) designs, manufactures and sells medical devices and software for the treatment of cancer and other medical conditions through radiotherapy, proton therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. The company’s major produ …
  • Graftys SA-医療機器分野:企業M&A・提携分析
    Summary Graftys SA (Graftys) is a medical device company that focuses on the development, manufacture and commercialization of synthetic bioactive orthopedic biomaterials. It provides a wide range of synthetic and bioresorbable bone graft substitutes and other cement products. The company’s products …
  • Xtant Medical Holdings Inc (XTNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • AF Gruppen ASA (AFG):企業の財務・戦略的SWOT分析
    AF Gruppen ASA (AFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Refresco Gerber B.V.:企業の戦略・SWOT・財務情報
    Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report Summary Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PolyNovo Ltd (PNV)-医療機器分野:企業M&A・提携分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd is a medical device company that develops, manufactures and commercializes biodegradable polymers for use in medical devices. The company offers products such as biodegradable temporizing matrix and negative pressure wound therapy dressing system …
  • Neuronetics Inc (STIM):医療機器:M&Aディール及び事業提携情報
    Summary Neuronetics Inc (Neuronetics) is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders. The company provides neurostar TMS therapy system used to treat patients with depressive disorder. Its neurostar TMS components comprise practice data ma …
  • Helix Energy Solutions Group, Inc.:企業の戦略・SWOT・財務情報
    Helix Energy Solutions Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Helix Energy Solutions Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Guangshen Railway Company Limited:戦略・SWOT・企業財務分析
    Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report Summary Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Transgene SA (TNG):企業の財務・戦略的SWOT分析
    Summary Transgene SA (Transgene) a subsidiary of Institut Merieux SA operates as a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develop …
  • Napp Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Napp Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Amryt Pharma plc (AMYT):製薬・医療:M&Aディール及び事業提携情報
    Summary Amryt Pharma plc (Amryt) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for patients with rare and orphan diseases. It has two marketed products include Lojuxta for the treatment of adult HoFH and Episalvan for the treatment of PTW. The …
  • KPMG International Coop:企業の戦略的SWOT分析
    KPMG International Coop - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Piramal Enterprises Ltd (PEL)-医療機器分野:企業M&A・提携分析
    Summary Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. I …
  • FPT Securities Joint Stock Company (FTS):企業の財務・戦略的SWOT分析
    FPT Securities Joint Stock Company (FTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ardelyx Inc (ARDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company provides product portfolio such as tenapanor, RDX227675, RDX98940 and RDX013, among others. Its products are used for hyperphosphatemia in …
  • Bukwang Pharm Co Ltd (003000)-製薬・医療分野:企業M&A・提携分析
    Summary Bukwang PharmCo Ltd (BUKWANG) is a pharmaceutical company which develops pharmaceutical products and new drugs. The company’s product portfolio includes levovir, legalon, dexid, thioctacid, lonasen, ixel, Orfil, azeptin, asima among others. Its pipeline products comprise MLR-1023, JM-010, JM …
  • Mr. Price Group Ltd.:戦略・SWOT・企業財務分析
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Guangzhou Wondfo Biotech Co Ltd (300482)-医療機器分野:企業M&A・提携分析
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that provides rapid diagnostic services. The company manufactures medical products and biochemical reagents. Its products include rapid test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆